Operating Income (Loss) in USD of Gossamer Bio, Inc. from 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Gossamer Bio, Inc. quarterly/annual Operating Income (Loss) history and change rate from 2017 to Q3 2025.
  • Gossamer Bio, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$49.1M, a 44.8% decline year-over-year.
  • Gossamer Bio, Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$161M, a 121% decline year-over-year.
  • Gossamer Bio, Inc. annual Operating Income (Loss) for 2024 was -$59.9M, a 67.4% increase from 2023.
  • Gossamer Bio, Inc. annual Operating Income (Loss) for 2023 was -$184M, a 15.9% increase from 2022.
  • Gossamer Bio, Inc. annual Operating Income (Loss) for 2022 was -$219M, a 1.14% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Gossamer Bio, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$161M -$49.1M -$15.2M -44.8% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 -$146M -$38.8M -$90.9M -174% 01 Apr 2025 30 Jun 2025 10-Q 05 Aug 2025
Q1 2025 -$54.8M -$36.8M +$5.15M +12.3% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q4 2024 -$59.9M -$36.1M +$12.9M +26.3% 01 Oct 2024 31 Dec 2024 10-K 13 Mar 2025
Q3 2024 -$72.8M -$33.9M +$6.57M +16.2% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025
Q2 2024 -$79.4M $52.1M +$98.4M 01 Apr 2024 30 Jun 2024 10-Q 05 Aug 2025
Q1 2024 -$178M -$42M +$5.98M +12.5% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q4 2023 -$184M -$49M +$5.33M +9.81% 01 Oct 2023 31 Dec 2023 10-K 13 Mar 2025
Q3 2023 -$189M -$40.5M +$15.5M +27.7% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 -$205M -$46.3M +$7.57M +14.1% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024
Q1 2023 -$212M -$47.9M +$6.4M +11.8% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024
Q4 2022 -$219M -$54.4M -$2.7M -5.22% 01 Oct 2022 31 Dec 2022 10-K 13 Mar 2025
Q3 2022 -$216M -$56M -$357K -0.64% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$216M -$53.9M +$1.72M +3.1% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023
Q1 2022 -$217M -$54.3M -$1.14M -2.14% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q4 2021 -$216M -$51.7M +$8.43M +14% 01 Oct 2021 31 Dec 2021 10-K 05 Mar 2024
Q3 2021 -$225M -$55.7M -$2.1M -3.91% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022
Q2 2021 -$222M -$55.6M +$9.74M +14.9% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 -$232M -$53.2M +$1.76M +3.21% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022
Q4 2020 -$234M -$60.1M -$4.3M -7.71% 01 Oct 2020 31 Dec 2020 10-K 17 Mar 2023
Q3 2020 -$230M -$53.6M -$3.58M -7.17% 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021
Q2 2020 -$226M -$65.3M -$19M -41% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021
Q1 2020 -$207M -$55M -$21M -61.6% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021
Q4 2019 -$186M -$55.8M -$16M -40.1% 01 Oct 2019 31 Dec 2019 10-K 24 Mar 2020
Q3 2019 -$170M -$50M +$38K +0.08% 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020
Q2 2019 -$170M -$46.3M -$13.3M -40.3% 01 Apr 2019 30 Jun 2019 10-Q 11 Aug 2020
Q1 2019 -$157M -$34M -$7.89M -30.2% 01 Jan 2019 31 Mar 2019 10-Q 12 May 2020
Q4 2018 -$149M -$39.8M 01 Oct 2018 31 Dec 2018 10-K 24 Mar 2020
Q3 2018 -$50M 01 Jul 2018 30 Sep 2018 10-K 24 Mar 2020
Q2 2018 -$33M 01 Apr 2018 30 Jun 2018 10-K 24 Mar 2020
Q1 2018 -$26.1M 01 Jan 2018 31 Mar 2018 10-K 24 Mar 2020

Gossamer Bio, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$59.9M +$124M +67.4% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2025
2023 -$184M +$34.8M +15.9% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025
2022 -$219M -$2.47M -1.14% 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2025
2021 -$216M +$17.8M +7.62% 01 Jan 2021 31 Dec 2021 10-K 05 Mar 2024
2020 -$234M -$47.8M -25.7% 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2023
2019 -$186M -$37.1M -24.9% 01 Jan 2019 31 Dec 2019 10-K 03 Mar 2022
2018 -$149M -$142M -2139% 01 Jan 2018 31 Dec 2018 10-K 26 Feb 2021
2017 -$6.65M 01 Jan 2017 31 Dec 2017 10-K 24 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.